You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
21 June 2024
Articles of Incorporation
24 May 2024
Annual Report 2023
25 April 2024
Organizational Regulations
Insider Regulations
17 April 2024
Annual financial report 2023
28 February 2024
19 July 2023
July 2023 Investor Presentation
31 May 2023
Annual financial report 2022
4 November 2022
Kinarus Therapeutics Provides Strategic Update
24 August 2022
Download slides from webinar on Kinarus’ new approach to treating COVID-19
31 March 2022
Annual financial report 2021
1 April 2021
Annual financial report 2020
31 March 2021
17 April 2020
Annual financial report 2019
29 March 2019
Annual financial report 2018
29 March 2018
Annual financial report 2017
31 March 2017
Annual financial report 2016
31 March 2016
Annual financial report 2015
31 March 2015
Annual financial report 2014
28 March 2014
Annual financial report 2013
29 March 2013
Annual financial report 2012
16 September 2024
Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs
12 September 2024
Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September
27 August 2024
Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA
25 July 2024
Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG publishes Annual Report of the (then still named) Kinarus Group for FY2023 and announces appointment of Chief Financial Officer
27
Mar 25
Publication annual financial report
23
May 25
Annual General Meeting
